Correlation Between Eton Pharmaceuticals and Tcr2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eton Pharmaceuticals and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eton Pharmaceuticals and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eton Pharmaceuticals and Tcr2 Therapeutics, you can compare the effects of market volatilities on Eton Pharmaceuticals and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eton Pharmaceuticals with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eton Pharmaceuticals and Tcr2 Therapeutics.
Diversification Opportunities for Eton Pharmaceuticals and Tcr2 Therapeutics
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Eton and Tcr2 is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Eton Pharmaceuticals and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Eton Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eton Pharmaceuticals are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Eton Pharmaceuticals i.e., Eton Pharmaceuticals and Tcr2 Therapeutics go up and down completely randomly.
Pair Corralation between Eton Pharmaceuticals and Tcr2 Therapeutics
Given the investment horizon of 90 days Eton Pharmaceuticals is expected to generate 0.82 times more return on investment than Tcr2 Therapeutics. However, Eton Pharmaceuticals is 1.22 times less risky than Tcr2 Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Tcr2 Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 345.00 in Eton Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 778.00 from holding Eton Pharmaceuticals or generate 225.51% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 18.02% |
| Values | Daily Returns |
Eton Pharmaceuticals vs. Tcr2 Therapeutics
Performance |
| Timeline |
| Eton Pharmaceuticals |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Eton Pharmaceuticals and Tcr2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eton Pharmaceuticals and Tcr2 Therapeutics
The main advantage of trading using opposite Eton Pharmaceuticals and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eton Pharmaceuticals position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.| Eton Pharmaceuticals vs. Connect Biopharma Holdings | Eton Pharmaceuticals vs. Acumen Pharmaceuticals | Eton Pharmaceuticals vs. Nuvation Bio | Eton Pharmaceuticals vs. Eledon Pharmaceuticals |
| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. Pieris Pharmaceuticals | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |